PDS Biotechnology Corporation

-0.07 (-1.42%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

PDS Biotechnology Corporation Stock, NASDAQ:PDSB

Florham Park, 25B Vreeland Road, Princeton, New Jersey 07932
United States of America
Phone: +1.800.208.3343
Number of Employees: 15


PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products PDS0101, is an off the shelf immunotherapeutic that is administered by subcutaneous injection. The company was founded by Frank K. Bedu-Addo on March 15, 2019 and is headquartered in Princeton, NJ.